Mikael Ørum
Chief Executive Officer at Acri Invest II ApS
Network origin in Mikael Ørum first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany.
15
| Private Company | Miscellaneous Commercial Services | 15 |
| Extinct | Biotechnology | 8 | |
| Extinct | Miscellaneous Commercial Services | 5 | |
RhoVac ApS
 RhoVac ApS Pharmaceuticals: MajorHealth Technology Part of Chosa Oncology AB, RhoVac ApS is a Danish company that aims to prevent cancer recurrence and progression after primary tumor therapy. The company is based in Hørsholm, Denmark. The company's clinical phase II product, iCIP™ - Precision LiPlaCis® & DRP® with Breakthrough designation option, consists of LiPlaCis® and its Drug Response. Anders Månsson has been the CEO of the company since 2019.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Ventac Partners A/S
 Ventac Partners A/S Miscellaneous Commercial ServicesCommercial Services Part of Ventac Partners GmbH, Ventac Partners A/S provides life science consulting services. The company is based in Copenhagen, Denmark. The CEO of the Danish company is Mikael Ørum.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Ventac Partners LLC
2
| Private Company | 2 | |
Neuroscience Technologies SLP
 Neuroscience Technologies SLP Medical/Nursing ServicesHealth Services Neuroscience Technologies SLP provides medical research and laboratory services for neurosciences. The private company is based in Barcelona, ES and has subsidiaries in United Kingdom. The CEO of the Spanish company is Neil Thomas.
1
| Private Company | Medical/Nursing Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mikael Ørum via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| Wallac Oy | Corporate Officer/Principal Director/Board Member | ||
PNA Diagnostics A/S
 PNA Diagnostics A/S Medical SpecialtiesHealth Technology PNA-Diagnostics A/S manufactures medical diagnostic equipment. The firm is a subsidiary of Applera Corp. The company is headquartered in Copenhagen, Denmark | Medical Specialties | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Technical University of Denmark | College/University | Doctorate Degree Director/Board Member | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Lund | College/University | Director/Board Member Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Lausanne | College/University | Doctorate Degree | |
| National & Kapodistrian University of Athens | College/University | Undergraduate Degree | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Graduate Degree | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
| Inveni Capital GmbH | Investment Managers | Private Equity Investor Private Equity Investor | |
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Chairman | |
miacom diagnostics GmbH
 miacom diagnostics GmbH BiotechnologyHealth Technology miacom diagnostics GmbH develops and distributes rapid molecular diagnostic tests for the identification of pathogens directly from patient material. Its products include hemoFISH Gram, hemoFISH Masterpanel, hemoFISH S.aureus and CNS Screen, respiFISH HAP Gram Panel, respiFISH HAP Masterpanel, FISH Probes, Combined hotplate and hybridization chamber, 8-channel pipette, and fluorescence microscopes. The company was founded by Ian Thrippleton and Walter Freiherr von Stein in 2009 and is headquartered in Düsseldorf, Germany. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Medexis Biotech SA | Chief Executive Officer | ||
| Proligo Biochemie Gmbh Hamburg | Corporate Officer/Principal | ||
Gerolymatos International SA
 Gerolymatos International SA Pharmaceuticals: MajorHealth Technology Part of Alapis Holding Industrial & Commercial SA, Gerolymatos International SA is a Greek company that manufactures and distributes pharmaceutical products. The company is based in Kryoneri, Greece. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Steno Diabetes Center A/S | Corporate Officer/Principal | ||
Regenesance BV
 Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | Drugstore Chains | Director/Board Member Chairman | |
| CASiGEN Pharma Ltd. | Founder Chairman | ||
Biovista, Inc.
 Biovista, Inc. Internet Software/ServicesTechnology Services Biovista, Inc. operates as an artificial intelligence platform to develop pipeline drugs. The firm offers drug repositioning, personalized medicine, drug de risking, clinical hold and pipeline services. The company was founded by Aris Persidis and Andreas Persidis and is headquartered in Charlottesville, VA. | Internet Software/Services | Corporate Officer/Principal | |
| Hoechst Group | Chief Executive Officer | ||
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Chairman Chairman | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree | |
| Preelumina Diagnostics AB | Director/Board Member Chairman | ||
| Hellenic Biotechnology Cluster | Founder | ||
| Zestagen AG | Founder Chairman | ||
| IDOGEN AB (PUBL) | Biotechnology | Corporate Officer/Principal Chief Executive Officer Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
| Apotech SA | Chief Tech/Sci/R&D Officer | ||
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman Chairman | |
| SCANDINAVIAN CHEMOTECH AB | Medical Specialties | Director/Board Member Chairman | |
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Corporate Officer/Principal Consultant / Advisor | |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Agricultural Commodities/Milling | Director/Board Member | |
Orbit Genomics, Inc.
 Orbit Genomics, Inc. Packaged SoftwareTechnology Services Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation. | Packaged Software | Founder Chairman | |
Asgard Therapeutics AB
 Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Asgard Therapeutics AB engages in biotechnological research and development activities. It is in use of cellular reprogramming in cancer immunotherapy, which forces cancer cells to present their own antigens to the immune system, triggering expansion of cancer cell-specific killer T cells and cancer elimination. The company was founded by Filipe Pereira, Cristiana Pires and Fábio Rosa in 2018 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| AEGIRBIO AB | Medical Specialties | Director/Board Member | |
| COEGIN PHARMA AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Lino Biotech AG
 Lino Biotech AG Miscellaneous Commercial ServicesCommercial Services Lino Biotech AG provides foal molography technology. It is a novel label-free biosensor platform for direct imaging of biomolecular interactions in living cells. The company was founded by Mirko Stange, Volker Gatterdam, and Andreas Fruter and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman Founder | |
Elastrin Therapeutics, Inc.
 Elastrin Therapeutics, Inc. BiotechnologyHealth Technology Elastrin Therapeutics, Inc. is a biotech company based in Simpsonville, SC. Elastrin Therapeutics is developing novel therapies to reverse cardiovascular disease using a proprietary platform that targets and restores degraded elastin by removing harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting. The company's treatment, a nanoparticle that specifically targets elastin, is able to reverse calcification in the arteries and other tissues, providing a solution to heart disease, stroke, high blood pressure, COPD, and aneurysm. The company was founded by Mirko Stange, Douglas Mulhall, Naren Vyavahare, Charles D. Rice, Valentin Busch, and Markus Zils. The CEO is Matthias Breugelmans. | Biotechnology | Founder | |
Genetrix SL
 Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Biotechnology | Corporate Officer/Principal | |
| Droege Group Internationale Unternehmer-Beratung GmbH | Corporate Officer/Principal |
Statistics
International
| Sweden | 13 |
| Denmark | 10 |
| Germany | 8 |
| United States | 8 |
| Switzerland | 5 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 3 |
Operational
| Director/Board Member | 124 |
| Corporate Officer/Principal | 78 |
| Chairman | 48 |
| Chief Executive Officer | 44 |
| Founder | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Seppo Olavi Mäkinen | 44 |
| Lars Olof Hedbys | 30 |
| Dennis Bang Henriksen | 19 |
| Mikael Oerum | 17 |
| Rolf Bertil Ehrnström | 17 |
| Neil Thomas | 16 |
| Hans Niclas Göran Lundqvist | 15 |
| Ulla Cristina Glad | 15 |
| Anders Månsson | 12 |
| Konstantinos Alevizopoulos | 11 |
| Gunnar Gårdemyr | 11 |
| Christina Wagner | 11 |
| Martin Austin | 11 |
| Bengt Arvid Westrin | 10 |
| Henrik Stage | 10 |
- Stock Market
- Insiders
- Mikael Ørum
- Company connections
